Kuros Biosciences AG (KURN) — Cash Flow Quality Index
Kuros Biosciences AG (KURN) has a Cash Flow Quality Index of 0.54x as of December 2025. Operating cash flow of CHF1.94 Million is below net income of CHF3.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore KURN cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kuros Biosciences AG Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Kuros Biosciences AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Kuros Biosciences AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Kuros Biosciences AG (2015–2025)
Year-by-year earnings quality comparison for Kuros Biosciences AG. For live market cap and the full company financial profile, see Kuros Biosciences AG stock valuation.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | CHF-377.87K | CHF2.04 Million | ▲ +54.2% |
| 2015 | -0.40x | CHF-2.51 Million | CHF6.23 Million | — |